The Associate Director Marketing for metabolic disease will have primary responsibility for the preparation and implementation of the launch for Lorcaserin, a new 5-HT 2c antagonist for the treatment of medical obesity. This person will be responsible for setting the strategic course for Lorcaserin’s launch. They will also be charged with shaping a clear, long-term strategy for Eisai to generate data through lifecycle management, and build a leadership position in this important market. It is ...
Eisai - 7 months ago
- save job
-
block
